@ontarget-podcast.bsky.socialJack Meehan, co-founder and analyst at Operon Research, talks about the where the diagnostics industry is now and where he sees it heading.
🎧 Listen now → www.ontargetpodcast.com
#OnTarget #PrecisionMedicine #AI #Diagnostics #LifeScienceTools #MCED #LiquidBiopsy #OperonResearch
@ontarget-podcast.bsky.socialMirna Jarosz, CEO of #LiquidCellDx, explains how her company's #liquidbiopsy captures information about the #tumormicroenvironment, providing critical treatment guidance.
🎧 Listen now → www.ontargetpodcast.com
#OnTarget #PrecisionMedicine #Oncology #Immunotherapy #CancerDiagnostics #AI
@newsen.bsky.socialFlagship Pioneering's Groundbreaking Partnership with the Pentagon for Medical Innovations #USA #Cambridge #Flagship_Pioneering #Department_of_War #ONTARGET
@ontarget-podcast.bsky.socialHamed Amini, CEO and co-founder of #Hepta Bio, tells us how his company's #liquidbiopsy can diagnose liver fibrosis due to MASH, identifying patients who are treatment candidates.
🎧 Listen now → www.ontargetpodcast.com
#OnTarget #PrecisionMedicine #MASH #Epigenetics #LiverDisease #Diagnostics #AI
@ontarget-podcast.bsky.social#AjitSingh, CEO of Harbinger Health, explains how his company's diagnostic determines whether a patient with nonspecific clinical signs has cancer.
🎧 Listen now → www.ontargetpodcast.com
#OnTarget #PrecisionMedicine #LiquidBiopsy #Oncology #AI #Diagnostics #HarbingerHealth #RESOLVE #EarlyDetection
